These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8532616)

  • 1. Dose-related efficiency of mono-n-hexyl meso-2,3-dimercaptosuccinate in decreasing 203Hg retention in rats.
    Kostial K; Blanusa M; Prester L; Jones MM; Singh PK
    Pharmacol Toxicol; 1995 Jul; 77(1):79-80. PubMed ID: 8532616
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoisoamyl and mono-n-hexyl meso-2,3-dimercaptosuccinate in mobilizing 203Hg retention in relation to age of rats and route of administration.
    Kostial K; Blanusa M; Piasek M; Prester L; Jones MM; Singh PK
    J Appl Toxicol; 1995; 15(3):201-6. PubMed ID: 7560740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing 203Hg retention by intraperitoneal treatment with monoalkyl esters of meso-2,3-dimercaptosuccinic acid in rats.
    Kostial K; Blanusa M; Simonović I; Jones MM; Singh PK
    J Appl Toxicol; 1993; 13(5):321-5. PubMed ID: 8258628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged oral treatment with two monoesters of meso-2,3-dimercaptosuccinic acid for depleting inorganic mercury retention in suckling rats.
    Kostial K; Blanusa M; Piasek M; Jones MM; Singh PK
    Pharmacol Toxicol; 1995 Sep; 77(3):216-8. PubMed ID: 8884886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racemic-2,3-dimercaptosuccinic acid for inorganic mercury mobilization in rats.
    Kostial K; Restek-Samarzija N; Blanusa M; Piasek M; Prester L; Jones MM; Singh PK
    J Appl Toxicol; 1997; 17(1):71-4. PubMed ID: 9048230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoisoamyl meso-2,3-dimercaptosuccinate as a delayed treatment for mercury removal in rats.
    Kostial K; Kargacin B; Blanusa M; Piasek M; Jones MM; Singh PK
    Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):309-11. PubMed ID: 7843123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority of Mi-ADMS to DMSA as parenteral treatment for decreasing mercury (203Hg) body burden in rats.
    Kostial K; Blanusa M; Piasek M; Simonović I; Jones MM; Singh PK
    Arh Hig Rada Toksikol; 1993 Sep; 44(3):217-22. PubMed ID: 8311694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of sodium dimercaptosuccinate for decrease of radiation burden of renal scintigraphy by chlormerodrin-203Hg.
    Vanlić-Razumenić NM; Paunković ND; Drasković RJ; Konstantinovska DD; Maksin TJ
    Int J Appl Radiat Isot; 1979 Aug; 30(8):473-80. PubMed ID: 225279
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of dimercaptosuccinic acid per os on distribution and excretion of 210Pb and 203Hg in mice].
    Liang YY; Zhang JS; Tao ZQ; Yan XM; Xu XH; Chen ZJ
    Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):379-82. PubMed ID: 7801787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined oral treatment with racemic and meso-2,3-dimercaptosuccinic acid for removal of mercury in rats.
    Kostial K; Restek-Samarzija N; Blanusa M; Piasek M; Jones MM; Singh PK
    Pharmacol Toxicol; 1997 Nov; 81(5):242-4. PubMed ID: 9396091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
    Juresa D; Blanusa M; Kostial K
    Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidotal effects of 2,3-dimercaptopropane-1-sulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the organotoxicity of dibutyltin dichloride (DBTC) in rats.
    Merkord J; Weber H; Kröning G; Hennighausen G
    Hum Exp Toxicol; 2000 Feb; 19(2):132-7. PubMed ID: 10773844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of an alleged mercury and lead exposure with DMPS].
    Hakimi R
    Versicherungsmedizin; 2014 Dec; 66(4):210-2. PubMed ID: 25558512
    [No Abstract]   [Full Text] [Related]  

  • 14. Mercury binding to the chelation therapy agents DMSA and DMPS and the rational design of custom chelators for mercury.
    George GN; Prince RC; Gailer J; Buttigieg GA; Denton MB; Harris HH; Pickering IJ
    Chem Res Toxicol; 2004 Aug; 17(8):999-1006. PubMed ID: 15310232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. meso-2,3-dimercaptosuccinic acid monoalkyl esters: effects on mercury levels in mice.
    Gale GR; Smith AB; Jones MM; Singh PK
    Toxicology; 1993 Jul; 81(1):49-56. PubMed ID: 8396277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of chelating agents on the distribution and biotransformation of methylmercuric chloride in rats.
    Planas-Bohne F
    J Pharmacol Exp Ther; 1981 May; 217(2):500-4. PubMed ID: 6262488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral therapy with monoisoamyl meso-2,3-dimercaptosuccinate on 203Hg retention in rats.
    Kostial K; Blanusa M; Piasek M; Jones MM; Singh PK
    Bull Environ Contam Toxicol; 1994 Apr; 52(4):492-7. PubMed ID: 8167441
    [No Abstract]   [Full Text] [Related]  

  • 18. Accumulation and removal of Hg203 in different regions of the rat brain.
    Butterworth RF; Gonce M; Barbeau A
    Can J Neurol Sci; 1978 Nov; 5(4):397-400. PubMed ID: 217517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of in vivo cadmium-mobilizing agents: synthesis and properties of monobenzyl meso-2,3-dimercaptosuccinate.
    Jones MM; Singh PK; Basinger MA; Gale GR; Smith AB; Harris WR
    Chem Res Toxicol; 1994; 7(3):367-73. PubMed ID: 8075368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats.
    Pingree SD; Simmonds PL; Woods JS
    Toxicol Sci; 2001 Jun; 61(2):224-33. PubMed ID: 11353131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.